AstraZeneca PLC ADR

Yahoo Finance • 5 hours ago

AP Top Extended Financial Headlines at 12:11 a.m. EDT

AstraZeneca has agreed to lower prescription drug costs for Medicaid under a deal with the Trump administration View Comments... Full story

Yahoo Finance • 5 hours ago

AP Top Financial News at 12:11 a.m. EDT

AstraZeneca agrees to lower drug prices for Medicaid under Trump administration deal View Comments... Full story

Yahoo Finance • 13 hours ago

SA Asks: What's the most attractive biotech stock right now?

[Genetic research and Biotech science Concept. Human Biology and pharmaceutical technology] jittawit.21 What's the most attractive biotech stock right now for investors? Seeking Alpha analysts ONeil Trader [https://seekingalpha.com/autho... Full story

Yahoo Finance • 2 days ago

AZN Quantitative Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for ASTRAZENECA PLC (ADR) (AZN). Of the 22 guru strategies we follow, AZN rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for... Full story

Yahoo Finance • 2 days ago

AstraZeneca to slash US drug prices as Trump pressures NHS to pay fair share

Pascal Soriot (left), AstraZeneca’s chief executive, has said the US has shouldered a “disproportionate portion” of drug costs - Alex Brandon/AP AstraZeneca has pledged to slash drug prices in the US as it pressures the NHS to pay more fo... Full story

Yahoo Finance • 2 days ago

AstraZeneca Strikes Drug-Pricing Deal With Trump Administration

The agreement, which entails offering “most-favored nation” drug pricing, follows Pfizer’s deal to reduce prices for its drugs sold in the Medicaid program and through a new direct-purchasing service to be branded TrumpRx. Continue Readin... Full story

Yahoo Finance • 2 days ago

AstraZeneca Cuts Discounted Drug Pricing Deal With the White House. The Stock Is Rising.

AstraZeneca on Friday became the second big drugmaker after Pfizer to cut a pricing deal with the White House, announcing an agreement alongside President Donald Trump at a late afternoon press conference. AstraZeneca stock was up 1.6% in... Full story

Yahoo Finance • 2 days ago

Trump announces US drug pricing deal with AstraZeneca

STORY: :: Trump says AstraZeneca will sell some medicines to the U.S. at discounted prices:: October 10, 2025:: Washington, D.C."Today, AstraZeneca is committing to offer all of their prescription medications to Medicaid at most favored na... Full story

Yahoo Finance • 3 days ago

AstraZeneca to Ink Drug-Pricing Deal With Trump Administration

AstraZeneca is the latest major drugmaker to strike a deal with the Trump administration on lowering U.S. drug prices, according to a person familiar with the matter. The agreement and its details, which have yet to be disclosed, follow la... Full story

Yahoo Finance • 3 days ago

Sector Update: Health Care Stocks Decline Late Afternoon

Health care stocks were lower late Friday afternoon, with the NYSE Health Care Index down 1.4% and t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 days ago

AstraZeneca to follow Pfizer lead in making drug price deal with Trump - report

[AstraZeneca company office building] Robert Way * President Trump at 5p ET Friday will say that AstraZeneca has made a deal with the Trump administration to cut the prices of its drugs, following in the footsteps of Pfizer's (PFE) agre... Full story

Yahoo Finance • 3 days ago

Sector Update: Health Care Stocks Decline Friday Afternoon

Health care stocks were lower Friday afternoon, with the NYSE Health Care Index and the Health Care PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 4 days ago

AstraZeneca plans to increase investment and scope of its Virginia manufacturing facility to $4.5 billion, creating 3,600 new jobs

New manufacturing facility to be located near Charlottesville, in Albemarle County, Virginia will develop and manufacture a broader range of medicines including weight management, metabolic and cancer technologies Facility marks cornersto... Full story

Yahoo Finance • 4 days ago

Lifespan-Backed Algen Biotechnologies Partners with AstraZeneca to Advance AI Drug Discovery

NORWALK, Conn., Oct. 9, 2025 /PRNewswire/ -- Lifespan Vision Ventures congratulates its portfolio company, Algen Biotechnologies, on the announcement of its multi-target research collaboration with AstraZeneca to advance AI-powered drug di... Full story

Yahoo Finance • 4 days ago

Turbine Launches Collaboration with AstraZeneca, Leveraging Turbine's Virtual Disease Models to Rationalize ADC Discovery

LONDON, UK and BUDAPEST, HUNGARY, Oct. 9, 2025 /PRNewswire/ -- Turbine, a leading company specializing in virtualizing biological experiments with AI, today announced a collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) to test the abili... Full story

Yahoo Finance • 4 days ago

Bispecific Antibodies Market - Global Forecast 2025-2032, Profiles of Key Players - F. Hoffmann-La Roche, Amgen, Janssen Biotech, Pfizer, AbbVie, Regeneron, MacroGenics, AstraZeneca, Merck, and Genmab

Company Logo The bispecific antibodies market presents key opportunities in oncology, autoimmune, and infectious diseases, driven by rapid technological advancements and strategic collaborations. Regional manufacturing and diverse supplie... Full story

Yahoo Finance • 4 days ago

UK Stocks Including Serica Energy That May Be Priced Below Intrinsic Estimates

The United Kingdom's stock market has recently faced challenges, as evidenced by the FTSE 100 index closing lower due to weak trade data from China and declining commodity prices affecting key sectors. In this environment, investors may fi... Full story

Yahoo Finance • 5 days ago

Mikael Dolsten, M.D., Ph.D., Joins TRIO Pharmaceuticals as Chairman

Mikael Dolsten, M.D., Ph.D., chairman of TRIO Pharmaceuticals SAN CARLOS, Calif., October 08, 2025--(BUSINESS WIRE)--TRIO Pharmaceuticals, a biotechnology company advancing novel multi-functional antibody treatments for cancers with high... Full story

Yahoo Finance • 5 days ago

AstraZeneca Shares Surge 14% as Investment Pause Spurs Fresh Valuation Debate

If you own AstraZeneca stock or are thinking about jumping in, this is one of those moments that begs your attention. With the share price rallying 14.3% in just the last week and up 20.2% since January, it is pretty obvious something is s... Full story

Yahoo Finance • 6 days ago

Neuromuscular Disease Therapeutics Market to Reach US$ 45.62 Billion by 2033 as Gene Therapies and RNA-based Treatments Redefine Patient Outcomes

AUSTIN, Texas and TOKYO, Oct. 7, 2025 /PRNewswire/ -- The Neuromuscular Disease Therapeutics Market is entering a period of accelerated growth, supported by breakthroughs in gene therapy, antisense oligonucleotides (ASOs), monoclonal antib... Full story